A microsimulation of 30 visual-inspection screen-and-treat policies for Ugandan women aged 25 to 49 found that 13% to 50% of cervical cancer deaths could be averted, at 88 to 313 US dollars per quality-adjusted life year, and that treating women who screen positive matters as much as screening more.
Published as "Optimising a national screen-and-treat cervical cancer strategy in Uganda: a microsimulation cost-effectiveness and budget impact analysis". The authors note that fewer than a third of Ugandan women have ever been screened and that current guidelines recommend screening women aged 25 to 49 every three years, and they model policies varying screening frequency, uptake and treatment follow-through over 15 years.
For Uganda's screening programme, making sure women who test positive are treated is a better use of money than screening more women without that follow-through.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/